Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Thyssenkrupp to suspend electrical steel production at French site - 2Are Saturn's rings made of a lost, shattered moon? New evidence arises for the case
- 3Charlotte faith leaders hold interfaith forum on Black and Palestinian solidarity
- 4German finance minister seeks better market access in China talks
- 5Somaliland denies trading recognition with Israel for accepting Gazans
- Europe picks companies to help build Argonaut moon lander
- Land Rover Just Unveiled Its Dakar Rally Defender
- As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
- Are Iraqi militias crossing into Iran to support Iran's war effort?
- Manual for Vegetarian Protein Powder
- Aid sent by ambulance to Ukraine front line
- 'Fertiliser costs mean I'm better off not planting'
- Doomed SpaceX Starlink satellite photographed from orbit
- Federal judge upholds Hawaii's new climate change tax on cruise passengers
